Pharming Group N.V. (AMS: PHARM)

Pharming Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,381	1,331	1,182	899.67	892.57	1,041
Revenue Growth (YoY)	9.39%	12.58%	31.36%	0.80%	-14.27%	13.84%
Cost of Revenue	1,108	1,057	929.91	690.88	708.47	831.7
Gross Profit	273.3	273.48	251.92	208.78	184.09	209.41
Selling, General & Admin	148.18	147.65	128.55	110.18	104.34	126.75
Other Operating Expenses	48.56	47.6	41.37	33.43	37.42	41.64
Operating Expenses	218.75	217.26	191.24	162.07	162.58	192
Operating Income	54.56	56.22	60.67	46.72	21.52	17.42
Interest Expense	-4.48	-4.23	-1.17	-0.62	-0.48	-1.03
Interest & Investment Income	0.9	0.9	0.55	0.6	0.76	0.62
Currency Exchange Gain (Loss)	-2.89	-2.89	-2.31	-0.7	-0.59	-0.57
EBT Excluding Unusual Items	48.09	50	57.74	46	21.21	16.44
Merger & Restructuring Charges	-	-	-	-0.87	-	-
Gain (Loss) on Sale of Assets	-	-	-10.43	-	-	-
Other Unusual Items	0.1	0.1	0.2	1.8	7.3	-
Pretax Income	48.19	50.1	47.5	46.93	28.51	16.44
Income Tax Expense	17.26	17.94	16.74	13.94	10.98	16.31
Earnings From Continuing Operations	30.93	32.16	30.76	32.99	17.54	0.13
Minority Interest in Earnings	-0.26	-0.51	-1.37	-1.99	-1.95	3.69
Net Income	30.67	31.65	29.39	31	15.59	3.83
Net Income to Common	30.67	31.65	29.39	31	15.59	3.83
Net Income Growth	-21.51%	7.70%	-5.19%	98.84%	307.58%	-81.41%
Shares Outstanding (Basic)	50	50	50	50	51	51
Shares Outstanding (Diluted)	50	50	51	50	51	51
Shares Change (YoY)	-0.38%	-0.15%	0.10%	-0.17%	-	-0.51%
EPS (Basic)	0.61	0.63	0.58	0.61	0.31	0.08
EPS (Diluted)	0.61	0.63	0.58	0.61	0.31	0.08
EPS Growth	-21.53%	8.28%	-4.92%	97.89%	307.59%	-81.09%
Free Cash Flow	42.76	4.74	23.25	14.5	88.95	15.61
Free Cash Flow Per Share	0.85	0.09	0.46	0.29	1.76	0.31
Dividend Per Share	0.550	0.550	0.550	0.450	0.300	-
Dividend Growth	0%	0%	22.22%	50.00%	-	-
Gross Margin	19.79%	20.55%	21.32%	23.21%	20.63%	20.11%
Operating Margin	3.95%	4.23%	5.13%	5.19%	2.41%	1.67%
Profit Margin	2.22%	2.38%	2.49%	3.45%	1.75%	0.37%
Free Cash Flow Margin	3.10%	0.36%	1.97%	1.61%	9.97%	1.50%
EBITDA	58.64	60.3	64.51	49	24	20.26
EBITDA Margin	4.24%	4.53%	5.46%	5.45%	2.69%	1.95%
D&A For EBITDA	4.08	4.08	3.83	2.28	2.49	2.84
EBIT	54.56	56.22	60.67	46.72	21.52	17.42
EBIT Margin	3.95%	4.23%	5.13%	5.19%	2.41%	1.67%
Effective Tax Rate	35.82%	35.81%	35.24%	29.70%	38.49%	99.19%

Source: S&P Capital IQ. Standard template. Financial Sources.